Franklin Resources’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Franklin Resources’s Portfolio BIB Stock Details BIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$70.1K	Hold	696	–	–	﹤0.01%	3021
2026 Q1	$56.7K	Hold	696	–	–	﹤0.01%	2995
2025 Q4	$55.5K	Hold	696	–	–	﹤0.01%	2972
2025 Q3	$41.5K	Hold	696	–	–	﹤0.01%	3026
2025 Q2	$31.9K	Buy	+696	New	+$30.6K	﹤0.01%	2932

Other funds holding BIB

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return

KFS

Kaizen Financial Strategies Campbell, California $308M AUM 41.73% 1-Year Est. Return

PWM

Palumbo Wealth Management Great Neck, New York $478M AUM 50.95% 1-Year Est. Return

Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return

CIC

Chase Investment Counsel Charlottesville, Virginia $474M AUM 95.11% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

ATPW

Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Franklin Resources's BIB Position: Q2 2026 in Review

Franklin Resources held its ProShares Ultra NASDAQ Biotechnology (BIB) position steady in Q2 2026 at 696 shares worth $70.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3021.

Franklin Resources first reported a position in BIB in Q2 2025 and has held it in 5 quarters since. 20 funds tracked by Wall St. Rank hold BIB as of Q2 2026.

Franklin Resources held 696 shares of ProShares Ultra NASDAQ Biotechnology worth $70.1K as of Q2 2026.
Franklin Resources left its ProShares Ultra NASDAQ Biotechnology share count unchanged in Q2 2026.
ProShares Ultra NASDAQ Biotechnology made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #3021 holding.
Franklin Resources first reported a position in ProShares Ultra NASDAQ Biotechnology in Q2 2025 and has held it in 5 quarters since.
20 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.